These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27106586)

  • 1. Binding Patterns Associated Aß-HSP60 p458 Conjugate to HLA-DR-DRB Allele of Human in Alzheimer's Disease: An In Silico Approach.
    Padmadas N; Panda PK; Durairaj S
    Interdiscip Sci; 2018 Mar; 10(1):93-104. PubMed ID: 27106586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
    Nemirovsky A; Fisher Y; Baron R; Cohen IR; Monsonego A
    Vaccine; 2011 May; 29(23):4043-50. PubMed ID: 21473952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp60, amateur chaperone in amyloid-beta fibrillogenesis.
    Mangione MR; Vilasi S; Marino C; Librizzi F; Canale C; Spigolon D; Bucchieri F; Fucarino A; Passantino R; Cappello F; Bulone D; San Biagio PL
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2474-2483. PubMed ID: 27474204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction structure of the complex between neuroprotective factor humanin and Alzheimer's β-amyloid peptide revealed by affinity mass spectrometry and molecular modeling.
    Maftei M; Tian X; Manea M; Exner TE; Schwanzar D; von Arnim CA; Przybylski M
    J Pept Sci; 2012 Jun; 18(6):373-82. PubMed ID: 22522311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homology modelling of frequent HLA class-II alleles: A perspective to improve prediction of HLA binding peptide and understand the HLA associated disease susceptibility.
    Kashyap M; Farooq U; Jaiswal V
    Infect Genet Evol; 2016 Oct; 44():234-244. PubMed ID: 27421208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of Ab initio predictions of peptide binding to MHC class II molecules.
    Zhang H; Wang P; Papangelopoulos N; Xu Y; Sette A; Bourne PE; Lund O; Ponomarenko J; Nielsen M; Peters B
    PLoS One; 2010 Feb; 5(2):e9272. PubMed ID: 20174654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
    Kashyap M; Jaiswal V; Farooq U
    Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
    Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A
    J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico and In Vitro Analysis of Interaction between Ximelagatran and Human Leukocyte Antigen (HLA)-DRB1*07:01.
    Hirasawa M; Hagihara K; Abe K; Ando O; Hirayama N
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28338626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp60 Protects against Amyloid β Oligomer Synaptic Toxicity via Modification of Toxic Oligomer Conformation.
    Marino C; Krishnan B; Cappello F; Taglialatela G
    ACS Chem Neurosci; 2019 Jun; 10(6):2858-2867. PubMed ID: 31091411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative molecular and three-dimensional analysis of the peptide-MHC II binding region in both human and Aotus MHC-DRB molecules confirms their usefulness in antimalarial vaccine development.
    Patarroyo ME; Cifuentes G; Baquero J
    Immunogenetics; 2006 Jul; 58(7):598-606. PubMed ID: 16791622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat Shock Proteins in Alzheimer's Disease: Role and Targeting.
    Campanella C; Pace A; Caruso Bavisotto C; Marzullo P; Marino Gammazza A; Buscemi S; Palumbo Piccionello A
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele.
    Zota V; Nemirovsky A; Baron R; Fisher Y; Selkoe DJ; Altmann DM; Weiner HL; Monsonego A
    J Immunol; 2009 Sep; 183(5):3522-30. PubMed ID: 19675171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHCII3D-Robust Structure Based Prediction of MHC II Binding Peptides.
    Laimer J; Lackner P
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building a meta-predictor for MHC class II-binding peptides.
    Huang L; Karpenko O; Murugan N; Dai Y
    Methods Mol Biol; 2007; 409():355-64. PubMed ID: 18450014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-arrhythmic Medication Propafenone a Potential Drug for Alzheimer's Disease Inhibiting Aggregation of Aβ: In Silico and in Vitro Studies.
    Ngo ST; Fang ST; Huang SH; Chou CL; Huy PD; Li MS; Chen YC
    J Chem Inf Model; 2016 Jul; 56(7):1344-56. PubMed ID: 27304669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of HLA-DR/DQ polymorphism with Alzheimer's disease.
    Mansouri L; Messalmani M; Klai S; Bedoui I; Derbali H; Gritli N; Mrissa R; Fekih-Mrissa N
    Am J Med Sci; 2015 Apr; 349(4):334-7. PubMed ID: 25651370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.